Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Investigating Non-response to Cardiac Resynchronization: Evaluation of Methods to Eliminate Non-response & Target Appropriate Lead Location (INCREMENTAL).

NCT00399594 is registered in ClinicalTrials.gov with University of Calgary as lead sponsor.

NCT NCT00399594
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00399594 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Investigating Non-response to Cardiac Resynchronization: Evaluation of Methods to Eliminate Non-response & Target Appropriate Lead Location (INCREMENTAL).
Lead sponsor
University of Calgary
Phase
Phase 2/3
Overall status
Completed
Start date
March 31, 2011
Completion date
November 30, 2015
Enrollment
96 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

cardiac pacing, artificial, defibrillators, heart failure, congestive